Dataset Information


Epigenome analysis of IDH1 mutant and IDH1/2 wild-type patient derived glioblastoma tumorsphere lines.

ABSTRACT: The aim of ths study is to compare global methylation status between 1) IDH1 mutant and IDH1/2 wild-type glioblastoma tumorsphere cells and 2) MGG152 (IDH1 mutant) with DMSO and IDH1 inhibitor treatment. Genome wide DNA methylation profiling of patient derived glioblastoma tumorsphere and HT1080 cells. The Illumina Infinium Human DNA methylation Beadchip450 was used to obtain DNA methylation profiles. Bisulphite converted DNA from the 10 samples and one control were hybridised to the Illumina Infinium Human Methylation Beadchip450. Please note that the MGG (in the sample title) represents patient-derived MGH glioblastoma cell lines. Regarding MGG152 samples, sample no.1 is low passage number and used for comparison between IDH1 mt and wild-type. Sample no. 2-4 were used for assessing DNA methylation change after short term or long term IDH1 inhibiting treatment.

ORGANISM(S): Homo sapiens  

SUBMITTER: Daniel P Cahill   Andrew S Chi  Kensuke Tateishi 

PROVIDER: E-GEOD-73270 | ArrayExpress | 2015-09-22



Similar Datasets

| GSE85938 | GEO
2012-08-13 | E-GEOD-31133 | ArrayExpress
2012-08-13 | E-GEOD-31126 | ArrayExpress
| GSE85941 | GEO
2016-03-10 | E-GEOD-74561 | ArrayExpress
| GSE85940 | GEO
| GSE66536 | GEO
2011-11-05 | E-GEOD-31337 | ArrayExpress
2012-07-22 | E-GEOD-38687 | ArrayExpress
2012-08-12 | E-GEOD-31134 | ArrayExpress